I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
C series
—
12.8.2024
(Appeal - Competition - Pharmaceutical products - Market for perindopril - Article 101 TFEU - Strategy to delay the market entry of generic versions of perindopril - Patent dispute settlement agreement - Licence and supply agreement)
(C/2024/4829)
Language of the case: French
Appellant: Biogaran SAS (represented by: O. de Juvigny, J. Jourdan, T. Reymond, A. Robert, avocats, J. Killick, advocaat, and M.I.F. Utges Manley, Solicitor)
Other party to the proceedings: European Commission (represented initially by F. Castilla Contreras, B. Mongin, and C. Vollrath, acting as Agents, and subsequently by F. Castilla Contreras and C. Vollrath, acting as Agents)
Intervener in support of the other party: United Kingdom of Great Britain and Northern Ireland (represented initially by D. Guðmundsdóttir, acting as Agent, and subsequently by S. Fuller, acting as Agent)
The Court:
1.Dismisses the appeal;
2.Orders Biogaran SAS to bear its own costs and to pay those incurred by the European Commission;
3.Orders the United Kingdom of Great Britain and Northern Ireland to bear its own costs.
—
(1)
OJ C 139, 15.4.2019.
ELI: http://data.europa.eu/eli/C/2024/4829/oj
ISSN 1977-091X (electronic edition)
—